跳至主要内容
临床试验/NCT02835482
NCT02835482终止不适用

Effect of Elevated Intraocular Pressure in Glaucoma Patients During Femtolaser Cataract Surgery

Fondation Ophtalmologique Adolphe de Rothschild2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2016年4月14日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
15
试验地点
2
主要终点
In patient with glaucoma, measure of the thickness of the ganglion cell complex in the operated eye with femtosecond laser versus the operated eye with phacoemulsification.

研究概览

简要总结

The use of the femtosecond laser causes an increase in the intraocular pressure (IOP) between 100 mm Hg and 200 mm Hg for a period of about 80 seconds (suction phase).

If it is known that elevated IOP accelerates the degradation of retinal ganglion cells, whose axons form the optic nerve.

No data has been published to date on potential adverse effects of femtolaser cataract surgery performed in patients with glaucomatous optic neuropathy.

Since some time, spectral-domain optical coherence tomography (SD -OCT) provides a detailed analysis of ganglion cell complex (GCC) for which the loss is a marker of glaucomatous optic neuropathy. The resolution of this device, about a few microns, can detect even a tiny loss of this layer.

The investigators propose to evaluate the effects of elevated intraocular pressure in glaucoma patients undergoing femtolaser cataract surgery, studying the GCC through SD-OCT.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

性别
All
接受健康志愿者

入选标准

  • scheduled bilateral cataract surgery
  • bilateral known glaucoma confirmed at the preoperative consultation (glaucoma group) or absence of glaucoma in both eyes at confirmed the preoperative consultation (control group).

排除标准

  • ophthalmologic pathology known other than glaucoma
  • untreated hypertension
  • multiple sclerosis
  • Graves' disease
  • sarcoidosis
  • patient taking toxic drug for the optic nerve and the retina
  • neurodegenerative disease
  • all general diseases that can affect the ocular structures
  • eye surgery history
  • patient's opposition to participation in the study, according to the law on research into routine care
  • absence of affiliation to social security or to universal medical coverage
  • legally protected patient
  • pregnancy or breastfeeding

研究组 & 干预措施

Patient with glaucoma

Experimental

Patient eligible for bilateral cataract surgery, with glaucoma. Each patient is his own control. The patient is treated with femtolaser surgery for one eye and with phacoemulsification for the other eye.

干预措施: Phacoemulsification (Procedure)

Patient without glaucoma

Other

Patient eligible for bilateral cataract surgery, without glaucoma. Each patient is his own control. The patient is treated with femtolaser surgery for one eye and with the phacoemulsification for the other eye.

干预措施: Femtolaser surgery (Procedure)

Patient without glaucoma

Other

Patient eligible for bilateral cataract surgery, without glaucoma. Each patient is his own control. The patient is treated with femtolaser surgery for one eye and with the phacoemulsification for the other eye.

干预措施: Phacoemulsification (Procedure)

Patient with glaucoma

Experimental

Patient eligible for bilateral cataract surgery, with glaucoma. Each patient is his own control. The patient is treated with femtolaser surgery for one eye and with phacoemulsification for the other eye.

干预措施: Femtolaser surgery (Procedure)

结局指标

主要结局

In patient with glaucoma, measure of the thickness of the ganglion cell complex in the operated eye with femtosecond laser versus the operated eye with phacoemulsification.

时间窗: within the first 3 months after surgery

次要结局

未报告次要终点

研究者

申办方类型
Network
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Effect of Elevated Intraocular Pressure in Glaucoma... | 临床试验